Pathology models

Pathology models

xxxx

xxxx

Read more
Preclinical CRO

Preclinical CRO

Preclinical Models

Read more
Preclinical imaging

Preclinical imaging

Access to various imaging modalities

Read more

Company

Preclinical efficacy CRO

IMAVITA is preclinical efficacy CRO company and an innovating contract research organization proposing preclinical services in the exploration of preclinical models of human pathologies by the use of innovating imaging techniques.
The vision of our company is to propose to pharmaceutical industries, biotechnology companies and other private & public laboratories, innovating solutions in efficacy / toxicity evaluation of active ingredients in laboratory species by the use of non invasive imaging techniques and appropriate imaging analysis for quantitative evaluation of specific imaging biomarkers.

IMAVITA is actually developing the following tools:

Preclinical efficacy CRO

IMAVITA is planning to focus its activities in the following domains:

IMAVITA has Research Tax Credit (CIR / “Crédit Impôt Recherche”) accreditation for years 2021 to 2023 (official accreditation available on request).

Imavita: Innovating preclinical services

for the evaluation of drug disposition and efficacy using quantitative imaging

Pre-clinical models

Preclinical model Imavita

for the early validation of tissue target and efficacy

In vivo imaging

Preclinical model Imavita

for the exploration of live animal preclinical models

Image Analysis

Image Analysis Imavita

to increase the throughput of your R&D pipeline